Income statement
USD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 69K | 0 | 0 |
| Gross Profit | 0 | 0 | 27K | 0 | 0 |
| Operating Income | -13M | -5M | -99K | -26K | -8K |
| EBITDA | -13M | -16M | -21M | -124K | -8K |
| Net Income | -14M | -16M | -17M | -125K | -15K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0004
-50.00% today
1Y Change
+300.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Virtual Medical International, Inc. (QEBR) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 300.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +40.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +40.6%, free cash flow +47.3% with operating margin 0.0% and ROIC -231.7%. Stock Foundry combines QEBR price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QEBR
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
QEBR Max Drawdown
-85.71%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for QEBR and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$14.7K
+88.2% YoY
Free Cash Flow
-$28.7K
-97.2% YoY
Revenue Growth
+0.0%
EPS Growth
+40.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 69K | 0 | 0 |
| Gross Profit | 0 | 0 | 27K | 0 | 0 |
| Operating Income | -13M | -5M | -99K | -26K | -8K |
| EBITDA | -13M | -16M | -21M | -124K | -8K |
| Net Income | -14M | -16M | -17M | -125K | -15K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2019 | 2018 |
|---|---|---|
| Cash & Equivalents | 56K | 0 |
| Total Assets | 6M | 5M |
| Total Liabilities | 187K | 21K |
| Shareholder Equity | 11M | 5M |
| Total Debt | 0 | 0 |
| Net Debt | -56K | 0 |
Cash flow positioning
Latest Full Year
Operating Cash Flow
29K
-97.2% YoY
Capital Expenditures
0
Free Cash Flow
29K
-97.2% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-171.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.